drugset / Trial / NCT01654120
Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine the effect of adding liraglutide to high dose insulin therapy compared to high dose insulin therapy alone in patients with insulin-treated Type 2 diabetes with insulin requirements of \> 100 units of insulin per day.
Timeline
- Start
- 2011-12
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | Subcutaneous |
| Subject | Liraglutide | Peptide | 1.8 mg | Subcutaneous |
| Subject | insulin aspart | Protein / enzyme biologic | — | Subcutaneous |
| Subject | insulin detemir | Protein / enzyme biologic | — | Subcutaneous |